Prevention and Treatment of Cytarabine-Induced Keratoconjunctivitis
Generalized benign cutaneous reaction to cytarabine. | Semantic Scholar
What Is Cytarabine?
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
Treatment of Leukemia with Low Dose Ara-C: A Study of 159 Cases *
ท่องโลกOnco - สวัสดียามดึกนะคะทุกคน... | Facebook
Ashley & Brooke Barlow PharmD on X: "#Oncopharm Memory Tip! 💡 What toxicities can you C 👁 with high dose (>1g/m2) C-ytarabine? ✓ 👁 C-onjunctivitis & C-orneal toxicity ✓🧠 C-erebellar syndrome Rx💊
Treatment modalities employed for remission-reinduction in relapsed/refractory AML – A review of current evidence
Frontiers | Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels
How I treat older patients with acute myeloid leukemia
PDF) Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia
SDRIFE Induced by Liposomal Daunorubicin and Cytarabine - Practical Dermatology
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte‐macrophage–colony stimulating factor (GM‐CSF) alternating with methotrexate and cytarabine plus rituximab and GM‐CSF in patients with ...
Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function - ScienceDirect
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial - The Lancet Haematology
Hematologic Malignancy for Internist 2014 Chinadol Wanitpongpun MD. - ppt download
IJMS | Free Full-Text | Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
Acute Promyelocytic Leukemia | PPT
Stem Cell Transplantation in Patients Affected by Shwachman-Diamond Syndrome: Expert Consensus and Recommendations From the EBMT Severe Aplastic Anaemia Working Party - Transplantation and Cellular Therapy, Official Publication of the American Society
Neurocognitive deficits in survivors of childhood acute myeloid leukemia | BMC Pediatrics | Full Text
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome | Leukemia
HIGH-DOSE ARA-C CEREBELLAR SYNDROME: REVIEW OF LITERATURE | Download Table
Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis
ホーム｜造血器腫瘍診療ガイドライン 2018年版補訂版｜一般社団法人 日本血液学会
